Use of Different Immunoresponse Assays for Evaluation of Live Attenuated Sheep Pox Vaccine in Comparison with Challenge Test

Sonia A. Rizk

Authors

Sonia A. Rizk

Keywords:

Abstract

Sheep pox (SP) is one of the priorities, high-impact animal diseases in many developing countries, where live attenuated vaccines are routinely used against sheep pox virus (SPV). Sheep pox virus is a member of the family Poxviridae, genus Capri poxvirus. In this study, live attenuated Sheep pox vaccines were evaluated for humoral and cellular immunity using virus neutralization index (NI), ELISA and lymphocyte proliferation assay (XTT) beside routinely titration of life attenuated virus content of vaccine in Vero cell line which gives mean satisfactory TCID50/dose (3.34) for used vaccine batches, in addition to clinical examination of vaccinated sheep and also application of challenge test. Sixty susceptible lambs were divided into (10) groups and vaccinated with field and safety doses of (10) different batches of live attenuated vaccine intradermal (I/D) in tail fold while three lambs kept as control. The results showed that lymphocyte proliferation began to increase till reach to its peak (1.312) at 10th day post vaccination then decrease after that with re-increasing after challenge , serological assays results revealed that protective serum antibody titer started at 10th day post vaccination with mean titer (1.6 and 1.99), mean absorbance (1.56 and 2.02) and at three weeks the mean titer (2.35 and 2.61) , mean absorbance (2.43 and 2.51) for NI and ELISA respectively, also all vaccinated lambs showed satisfactory levels of protection against the virulent SPV through challenge test as SID50 more than (2.5) for all batches of vaccine.

Downloads

How to Cite

Use of Different Immunoresponse Assays for Evaluation of Live Attenuated Sheep Pox Vaccine in Comparison with Challenge Test. (2018). Global Journal of Medical Research, 17(G2), 43-53. https://medicalresearchjournal.org/index.php/GJMR/article/view/1445

Download Citation

References

R Buller, Arif, Bm, Black, Dn (2005) Classification and Nomenclature of Viruses. 117.

R Kitching (2004) Sheep Pox. 2, 302-306.

T Rao, S Bandyopadhyay (2000) A comprehensive review of goat pox and sheep pox and their diagnosis. 1(2), 127-136.

D Kallesh, M Hosamani, V Balamurugan, V Bhanuprakash, V Yadav, R Singh (2009) Quantitative PCR: A quality control assay for estimation of viable virus content in live attenuated goat pox vaccine. 47, 911-915.

V Bhanuprakash, B Indrani, M Hosamani, R Singh (2006) The current status of sheep pox disease. 29(1), 27-60.

D Alan, R Lawrence (2009) Vaccines for biodefense and emerging and neglected diseases.

V Bhanuprakash, G Venkatesan, V Balamurugan (2010) Pox outbreaks in Sheep and Goats at Makhdoom (Uttar Pradesh), India: Evidence of Sheeppox Virus Infection in Goats. 57, 375-382.

R Kitching (1986) The control of sheep and goat pox. 5(2), 503-511.

Mirzaie Kamran, Seyed, Mohammad Barani, Saied Bokaie (2015) A review of sheep pox and goat pox: perspective of their control and eradication in Iran. 2(4), 373-381.

(2010) Chapter 2.7.14 Sheep pox and goat pox in manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 1-12.

E Tuppurainen, E Venter, J Shisler, G Gari, G Mekonnen, N Juleff, N Lyons, K De Clercq, C Upton, T Bowden, S Babiuk, L Babiuk (2017) Review: Capripoxvirus Diseases: Current Status and Opportunities for Control. 64(3), 729-745.

William Stokes, Karen Brown, Jodie Kulpa-Eddy, Geetha Srinivas, Marlies Halder, Hans Draayer, Jeffrey Galvin, Ivo Claassen, Glen Gifford, Ralph Woodland, Vivian Doelling, Brett Jones (2012) Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions. 5, 84-105.

G Aparna Madhavan, Amit Venkatesan, Kumar (2016) Capripoxviruses of Small Ruminants: Current Updates and Future Perspectives. 11(12), 757-770.

C Jungbäck (2012) Potency Testing of Veterinary Vaccines for Animals: The Way From in Vivo to in Vitro. 134, 149-152.

R Gibert, M Alberti, B Poirier, C Jallet, N Tordo, S Morgeaux (2013) A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release. 5(50), 6022-6029.

E Horváth, G Czifra, E Nagy, B Engström, M Mérza (1999) Potency test of inactivated Newcastle disease vaccines by monoclonal antibody blocking ELISA. 17(23-24), 2969-2973.

V Kubiak (2012) In vitro antigen measurement and potency tests: challenges encountered during method development...and lessons learned. 134, 83-91.

P Maas, M De Winter, S Venema, H Oei, I Claassen (2000) Antigen quantification asin vitroalternative for potency testing of inactivated viral poultry vaccines. 22(4), 223-227.

E Kamphuis, B Krämer, H Schildger, K Duchow (2012) Potency Testing of Inactivated Rabies Vaccines Using a Serological Method. 134, 23-27.

M Sabban (1960) Sheep pox and its control in Egypt. 33(3), 1527-1539.

C Rai-El-Balhaa, J Pellerin, G Bodin, A Abdullah, H Hiron (1985) Lymphocyte transformation assay of sheep peripheral blood lymphocyte a new rapid assay to read technique. 8(3/9), 311-318.

O Alvero, C Parlak, M Senyel (2006) FT-IR and NMR investigation of 1-phenylpiperazine: Acombined experimental and theoretical study.

P Rossiter, D Jessett, W M& Taylor (1985) Micro neutralization systems for use with different strains of PPR virus and rinderpest virus. 17(2), 75-81.

W Martin, M Erhan, B Onar (1975) Studies on sheep pox vaccine, serum -virus neutralization test. 8(1), 26-47.

J Anderson, L Rowe, W Taylor, J Crowther (1982) An enzyme linked immunosorbant assay for the detection of IgG, IgA and IgE antibodies. 32(2), 242-247.

S Kalra, U Sharma (1984) Cell-mediated and humoral immune response of sheep to attenuated sheep pox-virus. 54, 450-456.

R Amitha, Gomes; Raveendra Hegde, S Byregowda, Vijayashree Varadarajan, S Yeshwant, P Giridhar, C Renukaprasad (2010) of Evaluation of humoral immune response to sheep pox vaccine. 6(5), 236-238.

Judith Romberg, Stefan Lang, Elisabeth Balks, Elisabeth Kamphuis, Karin Duchow, Daniela Loos, Henriette Rau, Andreas Motitschke, Carmen Jungbäck (2012) Potency testing of veterinary vaccines: The way from in vivo to in vitro. 40(1), 100-106.

C Lewis, A Fry, J Hermann, D Siev, D Dusek, D Gatewood (2012) Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays. 134, 29-33.

Zeidan Zeidan, Namaa Mohamed, Hanan Elzawahr, Saad Saad, Olfat Nakhla, Afaf Abdel Wahab, Abeer Tammam, El Dakhly (2017) PRELIMINARY STUDY FOR PREPARATION OF COMBINED ATTENUATED VACCINE AGAINST SHEEP POX AND PPR VIRUSES. 4(4), 212-219.

(2017) Sheep pox and goat pox. 1-12.

M Mahmood, A Sajid, M Ahmad, Z Hassni, M Khan (1989) Expressing antigen in vertebrates by inoculation with recombinant virus-recombinant vaccine preparation; fowl-pox virus or canary-pox virus vector; antigen gene cloning and expression in Escherichia coli and mammal cell culture. 7(6), 574-574.

Zineb Boumart, ;, Samira Daouam, Imane Belkourati, Lamya Rafi, ; Eeva Tuppurainen; Khalid, Omari Tadlaoui, Mehdi Harrak (2016) Comparative innocuity and efficacy of live and inactivated sheeppox vaccines. 12, 133.

R Yogisharadhya, V Bhanuprakash, M Hosamani, G Venkatesan, V Balamurugan, D Bora, V Bhanot, M Prabhu, R Singh (2011) Comparative efficacy of live replicating sheeppox vaccine strains in. 39, 417-423.

V Carn (1993) Control of capripoxvirus infections. 11(13), 1275-1279.

A Bachh, G Ram, J Hopkins, M Bansal (1997) Observation on cellular response in experimentally sheep pox -infected lambs. 64, 263-266.

A Mohamed, M Mukhtar, A Elhussein, A Tageldin, M Fadol (2007) Immune response of sheep vaccinated with capripox vaccine. 1(1), 12-16.

E Olfat, S Nakhla; Samir, Manal, M Awad; Soad, Soliman, A Daoud (2002) Studies on cell mediated immune response of Goats vaccinated with Goat pox vaccine. 6, 139-151.

A Heba, Mohamed Khafagy, Abdelmoneim Abdelwahab, Mohamed Mustafa, Saad (2016) Preparation and field evaluation of live attenuated sheep pox vaccine for protection of calves against lumpy skin disease. 31(2), 1-7.

B Agag, S Mousa, H Hassan, M Saber, Nabila El-Deghidy, Aida El-Aziz (1992) Clinical, Serological and Biochemical Studies on Lumpy Skin Disease. 1(1), 13-23.

S Rashwan, H Al Khalaf, M Al Hammad, M Abdel-Baky, A Azab (2001) Determination of Sheep Pox Circulating Neutralizing Antibodies in Immunized Sheep and Goats in the North Region of the Kingdom of Saudi Arabia. 19(2), 233-235.

S Zeidan, Namaa Mohamed, Hananm Elzawahry, M Saad, E Olfat, Afaf Nakhla, Abeer Abdel-Wahab, Tammam, A El-Dakhly (2016) Preliminary study for preparation of cmbined attenuated vaccine against sheep pox and PPR viruses. 4(4), 212-219.

F Fakri, F Ghzal, S Daouam, A Elarkam, L Douieb, Y Zouheir, K Tadlaoui, O Fassi-Fihri (2015) Development and field application of a new combined vaccine against Peste des Petits Ruminants and Sheep Pox. 4, 33-37.